[1] KATSURA C,OGUNMWONYI I,KANKAM H K,et al. Breast cancer:presentation,investigation and management[J]. Br J Hosp Med (Lond),2022,83(2):1-7.
[2] YOU C P,LEUNG M H,TSANG W C,et al. Androgen receptor as an emerging feasible biomarker for breast cancer[J]. Biomolecules,2022,12(1):72.
[3] METOVIC J,BORELLA F,D′ AlONZO M,et al. FOXA1 in breast cancer:a luminal marker with promising prognostic and predictive impact[J]. Cancers (Basel),2022,14(19):4699.
[4] CRUZ-TAPIAS P,RUBIANO W,RONDON-LAGOS M,et al. Intrinsic subtypes and androgen receptor gene expression in primary breast cancer. A meta-analysis[J]. Biology(Basel),2021,10(9):834.
[5] YANG Y A,YU J. Current perspectives on FOXA1 regulation of androgen receptor signaling and prostate cancer[J]. Genes Dis,2015, 2(2):144-151.
[6] 中国抗癌协会乳腺癌专业委员会. 中国抗癌协会乳腺癌诊治指南与规范(2021年版)[J]. 中国癌症杂志,2021,31(10):954-1040.
[7] SIEGEL R L,MILLER K D,WAGLE N S,et al. Cancer statistics,2023[J]. CA Cancer J Clin,2023,73(1):17-48.
[8] 李华芳,丁新新.雄激素受体在HER-2+(HR-),HER-2+(HR+)及三阴性乳腺癌中的表达及临床病理分析[J].大连医科大学学报,2022,44(4):295-300.
[9] 袁小庆,邢益祥,赵铁. 雄激素受体(AR)在浸润性乳腺癌中的表达及其与乳腺癌分子分型的相关性[J]. 湖南师范大学学报(医学版),2021,18(4):252-255.
[10] BERNARDO G M,LOZADA K L,MIEDLER J D,et al. FOXA1 is an essential determinant of ERalpha expression and mammary ductal morphogenesis[J]. Development,2010,137(12):2045-2054.
[11] RANGEL N,FORTUNATI N,OSELLA-ABATE S,et al. FOXA1 and AR in invasive breast cancer:new findings on their co-expression and impact on prognosis in ER-positive patients[J]. BMC Cancer,2018,18(1):703.
[12] GUIU S,GHARON-BARRA C,VERNEREY D,et al. Coexpression of androgen receptor and FOXA1 in nonmetastatic triple-negative breast cancer:ancillary study from PACS08 trial[J]. Future Oncol,2015,11(16):2283-2297.
[13] DAGHER E,ROYER V,BUCHET P,et al. Androgen receptor and FOXA1 coexpression define a "luminal-AR" subtype of feline mammary carcinomas,spontaneous models of breast cancer[J]. BMC Cancer,2019,19(1):1267.
[14] KATOH M,IGARASHI M,FUKUDA H,et al. Cancer genetics and genomics of human FOX family genes[J]. Cancer Lett,2013,328(2):198-206.
[15] ROBINSON J L,MACARTHUR S,ROSS-INNES C S,et al. Androgen receptor driven transcription in molecular apocrine breast cancer is mediated by FoxA1[J]. EMBO J,2011,30(15):3019-3027.
[16] DI LEONE A,FRAGOMENI S M,SCARDINA L,et al. Androgen receptor expression and outcome of neoadjuvant chemotherapy in triple-negative breast cancer[J]. Eur Rev Med Pharmacol Sci,2021, 25(4):1910-1915.
[17] HORIMOTO Y,SASAHARA N,SASAKI R,et al. High FOXA1 protein expression might predict late recurrence in patients with estrogen-positive and HER2-negative breast cancer[J]. Breast Cancer Res Treat,2020,183(1):41-48.
[1]朱悦,张诗武,张丹芳,等.TA2小鼠自发乳腺癌血清蛋白质组学研究[J].天津医科大学学报,2013,19(05):373.
[2]刘 营,孙保存,刘铁菊,等.AURKA蛋白激酶在三阴乳腺癌干细胞形成血管拟态中的实验研究[J].天津医科大学学报,2013,19(06):437.
LIU Ying,SUN Bao-cun,LIU Tie-ju,et al.Experimental study of AURKA protein kinase in the formation of vascular mimicry in triple-negative breast cancer stem cells[J].Journal of Tianjin Medical University,2013,19(06):437.
[3]伦淑敏.HOXA5基因真核表达质粒的构建及在乳腺癌细胞中的功能研究[J].天津医科大学学报,2014,20(05):337.
LUN Shu-min. Construction of HOXA5 eukaryotic expression plasmid of and its biological significance in breast cancer cells[J].Journal of Tianjin Medical University,2014,20(06):337.
[4]伦淑敏.肌细胞增强因子2A基因真核表达质粒的构建及对乳腺癌细胞MCF-7增殖能力的影响[J].天津医科大学学报,2014,20(06):429.
LUN Shu-min.Construction of myocyte enhancer factor 2A eukaryotic expression plasmid and effects on cell proliferation in breast cancer cell line MCF7[J].Journal of Tianjin Medical University,2014,20(06):429.
[5]孙秀梅,张 飞,田 然,等.Nanog表达上调促进乳腺癌细胞MCF-7的增殖和侵袭[J].天津医科大学学报,2014,20(06):421.
SUN Xiu-mei,ZHANG Fei,TIAN Ran,et al.Up-regulation of Nanog promotes cell proliferation and invasion in breast cancer cells MCF-7[J].Journal of Tianjin Medical University,2014,20(06):421.
[6]张 洁,张 飞,冀 为,等. SHP2不同突变体对乳腺癌细胞的迁移和侵袭能力的影响[J].天津医科大学学报,2015,21(02):93.
ZHANG Jie,ZHANG Fei,JI Wei,et al. Effect of different SHP2 mutants on breast cancer cell migration and invasion[J].Journal of Tianjin Medical University,2015,21(06):93.
[7]蔡 隽. FOXQ1稳定表达乳腺癌细胞系的建立及鉴定[J].天津医科大学学报,2015,21(04):292.
CAI Jun.Establishment and identification of cell lines with stable expression of FOXQ1 in MDA-MB-231-luc[J].Journal of Tianjin Medical University,2015,21(06):292.
[8]蔡 隽 综述,冯玉梅 审校.叉头框转录因子调控乳腺癌生物学特性的研究进展[J].天津医科大学学报,2015,21(05):455.
[9]任宗娜.沉默Notch4基因对乳腺癌细胞系MDA-MB-231增殖和迁移侵袭能力的影响[J].天津医科大学学报,2015,21(06):469.
REN Zong-na.Inhibition effect of?silencing?? Notch4 gene on the proliferation and migration and invasion activity of? breast cancer cell line?MDA-MB-231[J].Journal of Tianjin Medical University,2015,21(06):469.
[10]周岩,宋伟杰,张飞,等.人附睾蛋白4在乳腺癌发生发展中的机制研究[J].天津医科大学学报,2015,21(06):466.
ZHOU Yan,SONG Wei-jie,ZHANG Fei,et al.Mechanism of human epididymis protein 4 in development and progression of breast cancer[J].Journal of Tianjin Medical University,2015,21(06):466.